TABLE 4.
Summary of FMEA performed by Younge et al. 88 for each step of 90Y microsphere therapy.
| Failure mode | Cause | Clinical impact |
|---|---|---|
| 1. Pre‐treatment imaging | ||
| scheduling the incorrect microsphere type |
|
|
| insufficient information on the planning study | ||
| incorrect measurement/recording of lung shunt fraction (LSF) |
|
|
| incorrect target identified |
|
|
| 2. Treatment planning | ||
| dosimetry worksheet error |
|
|
| treatment volume measured/recorded incorrectly | ||
| incorrect dose range used for cirrhotic/non‐cirrhotic patient | ||
| incorrect LSF entered in dosimetry worksheet | ||
| previous treatment not considered |
|
|
| gastrointestinal shunt not considered/recorded incorrectly | ||
| planning performed for wrong type of microspheres |
|
|
| 3. Dosage Ordering | ||
| dosage not ordered or ordered late |
|
|
| incorrect delivery date/time or incorrect requested calibration date/time |
|
|
| incorrect order form submitted | ||
| incorrect type of microspheres ordered | ||
| 4. Dosage Preparation | ||
| incorrect assay date/time recorded on check‐in paperwork |
|
|
| incorrect infusion date/time recorded on check‐in paperwork | ||
| incorrect dose calibrator factor used for assay | ||
| incorrect patient dosimetry worksheet used | ||
| not using aseptic techniques when assaying/preparing dosage | ||
| 5. Treatment administration | ||
| wrong patient |
|
|
| catheter incorrectly placed (i.e., wrong site) | ||
| incorrect vial/dose used | ||
| kinks/resistance/clogs in administration catheter after treatment initiation |
|
|
| vendor‐specific instructions not followed for administration | ||
| lung shunting not verified pretreatment |
|
|
| system disconnection (lines disconnecting, needles pulled out of vial, etc) during or after administration |
|
|